ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Shire Pharmaceuticals Group

Shire Pharmaceuticals Group is a dissolved company incorporated on 1 January 1994 with the registered office located in London, Greater London. Shire Pharmaceuticals Group was registered 31 years ago.
Status
Dissolved
Dissolved on 18 July 2023 (2 years 3 months ago)
Was 29 years old at the time of dissolution
Via voluntary strike-off
Company No
02883758
Private unlimited company
Age
31 years
Incorporated 1 January 1994
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Confirmation
Not Submitted
Awaiting first confirmation statement
Accounts
Not Submitted
Awaiting first accounts
Address
1 Kingdom Street
London
W2 6BD
United Kingdom
Same address for the past 8 years
Telephone
01256894000
Email
Available in Endole App
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • Finance Director • American • Lives in England • Born in Mar 1981
Director • Turkish • Lives in England • Born in Mar 1979
Shire Biopharmaceuticals Holdings
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Shire Pharmaceutical Contracts Limited
Peter Michael Grubin and Seyda Atadan Memis are mutual people.
Active
Shire Pharmaceuticals Limited
Peter Michael Grubin and Seyda Atadan Memis are mutual people.
Active
Takeda UK Limited
Peter Michael Grubin and Seyda Atadan Memis are mutual people.
Active
Takeda Development Centre Europe Ltd
Peter Michael Grubin and Seyda Atadan Memis are mutual people.
Active
Takeda Cambridge Limited
Peter Michael Grubin is a mutual person.
Active
Gammadelta Therapeutics Ltd
Seyda Atadan Memis is a mutual person.
Active
Adaptate Biotherapeutics Ltd
Seyda Atadan Memis is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2010–2020)
Period Ended
31 Mar 2020
For period 31 Dec31 Mar 2020
Traded for 15 months
Cash in Bank
£279K
Increased by £279K (%)
Turnover
£231.57M
Decreased by £8.04M (-3%)
Employees
64
Decreased by 2 (-3%)
Total Assets
£799.86M
Increased by £359.59M (+82%)
Total Liabilities
-£85.87M
Decreased by £40.89M (-32%)
Net Assets
£713.98M
Increased by £400.48M (+128%)
Debt Ratio (%)
11%
Decreased by 18.06% (-63%)
Latest Activity
Voluntarily Dissolution
2 Years 3 Months Ago on 18 Jul 2023
Takeda Corporate Services Limited Resigned
2 Years 5 Months Ago on 31 May 2023
Voluntary Gazette Notice
2 Years 6 Months Ago on 2 May 2023
Application To Strike Off
2 Years 6 Months Ago on 19 Apr 2023
Jonathan Clark Neal Resigned
2 Years 9 Months Ago on 18 Jan 2023
Mark Gibbons Resigned
3 Years Ago on 8 Nov 2022
Ms Seyda Atadan Memis Appointed
3 Years Ago on 1 Aug 2022
Confirmation Submitted
3 Years Ago on 4 Jul 2022
Peter Michael Grubin Appointed
3 Years Ago on 1 Mar 2022
Kentaro Shirahata Resigned
3 Years Ago on 1 Mar 2022
Get Credit Report
Discover Shire Pharmaceuticals Group's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Final Gazette dissolved via voluntary strike-off
Submitted on 18 Jul 2023
Termination of appointment of Takeda Corporate Services Limited as a secretary on 31 May 2023
Submitted on 2 Jun 2023
First Gazette notice for voluntary strike-off
Submitted on 2 May 2023
Application to strike the company off the register
Submitted on 19 Apr 2023
Resolutions
Submitted on 17 Apr 2023
Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023
Submitted on 26 Jan 2023
Termination of appointment of Mark Gibbons as a director on 8 November 2022
Submitted on 10 Nov 2022
Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022
Submitted on 23 Aug 2022
Confirmation statement made on 23 June 2022 with no updates
Submitted on 4 Jul 2022
Termination of appointment of Kentaro Shirahata as a director on 1 March 2022
Submitted on 21 Mar 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year